全文获取类型
收费全文 | 2511篇 |
免费 | 222篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 53篇 |
妇产科学 | 32篇 |
基础医学 | 451篇 |
口腔科学 | 82篇 |
临床医学 | 282篇 |
内科学 | 505篇 |
皮肤病学 | 48篇 |
神经病学 | 203篇 |
特种医学 | 87篇 |
外科学 | 310篇 |
综合类 | 4篇 |
预防医学 | 216篇 |
眼科学 | 20篇 |
药学 | 168篇 |
中国医学 | 7篇 |
肿瘤学 | 244篇 |
出版年
2024年 | 6篇 |
2023年 | 34篇 |
2022年 | 31篇 |
2021年 | 85篇 |
2020年 | 59篇 |
2019年 | 85篇 |
2018年 | 171篇 |
2017年 | 94篇 |
2016年 | 114篇 |
2015年 | 127篇 |
2014年 | 122篇 |
2013年 | 186篇 |
2012年 | 297篇 |
2011年 | 306篇 |
2010年 | 108篇 |
2009年 | 85篇 |
2008年 | 187篇 |
2007年 | 161篇 |
2006年 | 141篇 |
2005年 | 115篇 |
2004年 | 77篇 |
2003年 | 46篇 |
2002年 | 45篇 |
2001年 | 4篇 |
2000年 | 4篇 |
1999年 | 3篇 |
1998年 | 1篇 |
1992年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1972年 | 6篇 |
1971年 | 5篇 |
1970年 | 1篇 |
1923年 | 1篇 |
排序方式: 共有2740条查询结果,搜索用时 15 毫秒
1.
2.
Aurélie Daelemans Thierry Leloup Christine Decaesteker Albert De Mey 《Nordisk plastikkirurgisk forening [and] Nordisk klubb for handkirurgi》2006,40(6):335-344
Our aim was to develop and validate a new method to assess objectively and quantitatively the morphology of the nostrils after nasal or nasolabial surgery. We used digital analysis using specific mathematical algorithms to assess several geometric measurements, particularly of facial asymmetry, expressed in adimensional units. Forty-five patients with no facial anomalies (control group) were used initially to evaluate the method and to obtain variables for statistical reference. Thirty-five patients operated on for unilateral cleft lip and palate (cleft group) were then analysed and compared with the control group. Individual scores were obtained for each patient, computed, and correlated with those established by a lay panel. Statistical analysis showed good sensitivity and reliability (R>0.8). 相似文献
3.
Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease. 总被引:9,自引:0,他引:9
Aurélie Funkiewiez Claire Ardouin Paul Krack Valérie Fraix Nadège Van Blercom Jing Xie Elena Moro Alim-Louis Benabid Pierre Pollak 《Movement disorders》2003,18(5):524-530
High-frequency deep brain stimulation (DBS) of the subthalamic nucleus (STN) improves the motor symptoms of Parkinson's disease (PD). Opposite changes in mood, such as mania or depression, have been reported after surgery, but it is not known whether these side effects are specifically related to STN DBS. To learn whether STN DBS also influences the limbic loop, we investigated acute subjective psychotropic effects related to levodopa or bilateral STN DBS. After a median postoperative follow-up of 12 months, 50 PD patients completed the Addiction Research Center Inventory (ARCI), assessing subjective psychotropic effects in four conditions: off-drug/on-stimulation; off-drug/off-stimulation; on-drug/off-stimulation; and on-drug/on-stimulation. Both levodopa and STN DBS improved all the ARCI subscales, indicating subjective feelings of well being, euphoria, increase in motivation, and decrease in fatigue, anxiety, and tension. A suprathreshold dose of levodopa was significantly more effective than STN DBS, using the same electrical parameters as for chronic stimulation, on four of the five ARCI subscales. We concluded that 1) both STN DBS and levodopa have synergistic acute beneficial psychotropic effects in PD, 2) the psychotropic effects of both treatments need to be considered in the long-term management of chronic STN DBS, and 3) the results indicate an involvement of the limbic STN in mood disorders of PD. 相似文献
4.
Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia 总被引:1,自引:0,他引:1
C H Pui R J Aur W P Bowman G V Dahl R K Dodge S L George J Ochs D K Kalwinsky M Abromowitch H O Hustu 《Cancer research》1984,44(8):3593-3598
This clinical study, begun in 1975, tested the efficacy of early and delayed intensification treatments in children with acute lymphoblastic leukemia. Regardless of presenting features, all patients received 4 weeks of conventional induction therapy with daily prednisone and weekly vincristine and daunorubicin. One-third were randomized to receive, in addition, two doses of asparaginase during induction therapy, while another one-third received four doses of both asparaginase and cytarabine after remission induction. Preventive central nervous system therapy uniformly included 2400 rads cranial irradiation and five doses of intrathecal methotrexate. Remissions were maintained with daily p.o. mercaptopurine and weekly i.v. methotrexate. Of the 277 assessable patients, 254 (92%) entered complete remission, and 102 (37%) remain clinically free of leukemia for 4.6 to 8.0 years (median, 6.3 years). The three treatment groups showed no significant differences in either remission induction rate or outcome, even when the analysis was based on risk assignment. A "late intensification" phase of therapy, added to the maintenance protocol for 65 patients who had been in continuous complete remission for 14 to 30 months, failed to extend remission durations, as judged from statistical comparison with matched controls (p = 0.84). When tested as a time-dependent covariate in the Cox proportional-hazards model, delayed intensification again showed no important effect on duration of complete remission. We conclude that limited early or aggressive late intensification of therapy, as described here, does not improve outcome in childhood acute lymphoblastic leukemia. 相似文献
5.
Pascal Sève Sylvie Isaac Olivier Trédan Pierre-Jean Souquet Yves Pachéco Maurice Pérol Laurence Lafanéchère Aurélie Penet Eva-Laure Peiller Charles Dumontet 《Clinical cancer research》2005,11(15):5481-5486
PURPOSE: To determine the prevalence and the prognostic value of microtubule component expression in tumors of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). EXPERIMENTAL DESIGN: Expression of microtubular components was immunohistochemically examined in 93 tumor samples from untreated patients with stage III and IV NSCLC. All patients received vinorelbine-based chemotherapy. Response to chemotherapy, progression-free survival, and overall survival were correlated with the expression of microtubule proteins. RESULTS: The response rate was 27.3% (21 partial responses among 77 valuable patients). Although expression of microtubule components was not associated with the response rate, high class III beta-tubulin expression was correlated with resistance to vinorelbine, defined as disease progression under treatment. Patients whose tumors expressed high levels of class III beta-tubulin isotype had shorter progression-free survival and overall survival (P = 0.002 and 0.001, respectively). High Delta2 alpha-tubulin expression was associated with a shorter overall survival (P = 0.018). Tubulin II levels were not found to be correlated with patient outcome. A multivariate analysis, taking into account sex, age, histology, stage, weight loss, and class II beta-tubulin, class III beta-tubulin, and Delta2 alpha-tubulin levels, confirmed that class III beta-tubulin expression was independently correlated with progression-free survival (P = 0.04) and overall survival (P = 0.012). CONCLUSIONS: These findings suggest that a high level of expression of class III beta-tubulin in tumor cells is associated with resistance to vinorelbine and a poor prognosis in patients with NSCLC receiving vinorelbine-based chemotherapy. 相似文献
6.
Sentilhes L Patrier S Chouchene S Diguet A Berthier A Marpeau L Verspyck E 《Fetal diagnosis and therapy》2007,22(1):51-54
To date, the number of cases reported after exposure to mifepristone alone in early pregnancy is limited. In 24 cases, only 1 observation of fetal malformation associated with mifepristone has previously been reported. We report a case of amniotic band syndrome with limb amputation after exposure to mifepristone in early pregnancy. This association raises the question of a possible causal relationship. 相似文献
7.
8.
9.
Mihai?Dorin?Vartolomei Romain?Mathieu Vitaly?Margulis Jose?A.?Karam Morgan?Rouprêt Ilaria?Lucca Aurélie?Mbeutcha Christian?Seitz Pierre?I.?Karakiewicz Harun?Fajkovic Christopher?G.?Wood Alon?Z.?Weizer Jay?D.?Raman Nathalie?Rioux-Leclercq Andrea?Haitel Karim?Bensalah Michael?Rink Alberto?Briganti Evanguelos?Xylinas Shahrokh?F.?Shariat
Objective
Several retrospective studies with small cohorts reported neutrophil-to-lymphocyte ratio (NLR) as a prognostic marker in upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU). We aimed at validating the predictive and prognostic role of NLR in a large multi-institutional cohort.Methods
Preoperative NLR was assessed in a multi-institutional cohort of 2477 patients with UTUC treated with RNU. Altered NLR was defined by a ratio >2.7. Logistic regression analyses were performed to assess the association between NLR and lymph node metastasis, muscle-invasive and non-organ-confined disease. The association of altered NLR with recurrence-free survival (RFS) and cancer-specific survival (CSS) was evaluated using Cox proportional hazards regression models.Results
Altered NLR was observed in 1428 (62.8 %) patients and associated with more advanced pathological tumor stage, lymph node metastasis, lymphovascular invasion, tumor necrosis and sessile tumor architecture. In a preoperative model that included age, gender, tumor location and architecture, NLR was an independent predictive factor for the presence of lymph node metastasis, muscle-invasive and non-organ-confined disease (p < 0.001). Within a median follow-up of 40 months (IQR 20–76 months), 548 (24.1 %) patients experienced disease recurrence and 453 patients (19.9 %) died from their cancer. Compared to patients with normal NLR, those with altered NLR had worse RFS (0.003) and CSS (p = 0.002). In multivariable analyses that adjusted for the effects of standard clinicopathologic features, altered NLR did not retain an independent value. In the subgroup of patients treated with lymphadenectomy in addition to RNU, NLR was independently associated with CSS (p = 0.03).Conclusion
In UTUC, preoperative NLR is associated with adverse clinicopathologic features and independently predicts features of biologically and clinically aggressive UTUC such as lymph node metastasis, muscle-invasive or non-organ-confined status. NLR may help better risk stratify patients with regard to lymphadenectomy and conservative therapy.10.
Vaxillaire M Cavalcanti-Proença C Dechaume A Tichet J Marre M Balkau B Froguel P;DESIR Study Group 《Diabetes》2008,57(8):2253-2257
OBJECTIVE— Hepatic glucokinase (GCK) is a key regulator of glucose storage and disposal in the liver, where its activity is competitively modulated, with respect to glucose, by binding to glucokinase regulatory protein (GCKR) in the presence of fructose 6-phosphate. Genome-wide association studies for type 2 diabetes identified GCKR as a potential locus for modulating triglyceride levels. We evaluated, in a general French population, the contribution of the GCKR rs1260326-P446L polymorphism to quantitative metabolic parameters and to dyslipidemia and hyperglycemia risk.RESEARCH DESIGN AND METHODS— Genotype effects of rs1260326 were studied in 4,833 participants from the prospective DESIR (Data from an Epidemiological Study on the Insulin Resistance syndrome) cohort both at inclusion and using the measurements at follow-up.RESULTS— The minor T-allele of rs1260326 was strongly associated with lower fasting glucose (−1.43% per T-allele; P = 8 × 10−13) and fasting insulin levels (−4.23%; P = 3 × 10−7), lower homeostasis model assessment of insulin resistance index (−5.69%; P = 1 × 10−8), and, conversely, higher triglyceride levels (3.41%; P = 1 × 10−4) during the 9-year study. These effects relate to a lower risk of hyperglycemia (odds ratio [OR] 0.79 [95% CI 0.70–0.88]; P = 4 × 10−5) and of incident cases during the study (hazard ratio [HR] 0.83 [0.74–0.95]; P = 0.005). Moreover, an additive effect of GCKR rs1260326(T) and GCK (−30G) alleles conferred lower fasting glycemia (P = 1 × 10−13), insulinemia (P = 5 × 10−6), and hyperglycemia risk (P = 1 × 10−6).CONCLUSIONS— GCKR-L446 carriers are protected against type 2 diabetes despite higher triglyceride levels and risk of dyslipidemia, which suggests a potential molecular mechanism by which these two components of the metabolic syndrome can be dissociated.The enzyme glucokinase (GCK) is the major glucose sensor of the pancreatic β-cells, where it adapts insulin secretion to blood glucose levels. GCK also participates in regulating glycogen synthesis and gluconeogenesis in the liver (1). GCK activity is allosterically controlled in hepatocytes by the glucokinase regulatory protein (GCKR), which reversibly binds to GCK and inhibits its activity in the presence of fructose 6-phosphate. GCKR acts as a competitive inhibitor of GCK with respect to glucose and is suppressed by the specific metabolite fructose 1-phosphate (2).In GCKR-deficient mice, the disruption of this regulation and the subsequent decrease in GCK activity leads to altered glucose metabolism and impaired postprandial glycemic control (3,4), although no change in fasting blood glucose concentration is observed. Adenoviral-mediated hepatic overexpression of GCKR in mice with high-fat diet–induced diabetes improves fasting and glucose-induced glycemia and leads to a concomitant increase in insulin sensitivity and triglyceride levels and a decrease in leptin levels (5). Heterozygous mutations in GCK resulting in a reduction of enzymatic activity are responsible for a subtype of monogenic diabetes (maturity-onset diabetes of the young-2) (1,6). Previous genetic studies at the GCKR locus have not reported intragenic mutations associated with type 2 diabetes in humans (7,8).The Diabetes Genetics Initiative (DGI) genome-wide association study for type 2 diabetes and quantitative metabolic traits reported an intronic polymorphism of GCKR (rs780094) explaining interindividual variability in plasma triglyceride (TG) levels and a trend toward association with lower fasting glycemia, less insulin resistance, and lower risk for type 2 diabetes (9). The HapMap II CEU data (www.hapmap.org) showed that rs780094 is in strong linkage disequilibrium (r2 = 0.932) with a non-synonymous GCKR variant (Pro446Leu, rs1260326) that we previously identified by the DNA sequencing of French individuals (7). Marju Orho-Melander and colleagues recently communicated their fine-mapping data showing the strongest signal for TG levels at the coding single nucleotide polymorphism (SNP) (rs1260326; P = 1.5 × 10−9), with lesser associations to fasting glycemia and insulin sensitivity (M. Orho-Melander, O. Melander, V. Lyssenko, for the DGI, unpublished data). Similar findings for the intronic variant rs780094 were reported in a Danish population (10).We evaluated the association between GCKR rs1260326-P446L and TG levels in a middle-aged general French population with a follow-up of 9 years (11). Given the key role of GCKR in hepatic glucose metabolism, we also assessed the effect of rs1260326 on glucose homeostasis parameters and on the risk of impaired fasting glycemia and type 2 diabetes. Furthermore, as we previously showed a strong association of the GCK (−30A) promoter variant (rs1799884) to increased fasting glycemia and type 2 diabetes risk in the same study cohort (11), we also assessed possible additive effects of GCKR rs1260326-P446L and GCK −30G/A SNPs on fasting glucose, insulin, TG levels, and hyperglycemia risk. 相似文献